Copyright
©The Author(s) 2025.
World J Diabetes. Mar 15, 2025; 16(3): 97336
Published online Mar 15, 2025. doi: 10.4239/wjd.v16.i3.97336
Published online Mar 15, 2025. doi: 10.4239/wjd.v16.i3.97336
Figure 4 Optical density.
A: The effect of glabridin and gymnemic acid on the immunoreactive cytokines of the choroidal layer in five groups of rats at 8 weeks. A representative graph presents the relative vascular endothelial growth factor optical density in the choroidal layer; B: The relative cluster of differentiation 31 optical density in choroidal layer was analyzed. aP < 0.01. bP < 0.001. 1P calculated in the diabetic group when compared with the control, diabetic rats treated with glabridin 40 mg/kg body weight group, diabetic rats treated with gymnemic acid 400 mg/kg body weight group, and diabetic rats treated with glyburide 4 mg/kg body weight group. 2P calculated in the diabetic group when compared with the control group. VEGF: Vascular endothelial growth factor; CD: Cluster of differentiation; DM: Diabetic; DM + GB: Diabetic rats treated with glabridin 40 mg/kg body weight; DM + GM: Diabetic rats treated with gymnemic acid 400 mg/kg body weight; DM + GR: Diabetic rats treated with glyburide 4 mg/kg body weight.
- Citation: Matsathit U, Komolkriengkrai M, Khimmaktong W. Glabridin and gymnemic acid alleviates choroid structural change and choriocapillaris impairment in diabetic rat’s eyes. World J Diabetes 2025; 16(3): 97336
- URL: https://www.wjgnet.com/1948-9358/full/v16/i3/97336.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i3.97336